Onward's FY25 update shows solid commercial execution, although results came in slightly below expectations. The company sold 117 ARC-EX devices (KBCSe: 128) and generated € 5.4m in revenue (VA CSS: € 6.7m). However, we note that the ARC-EX system is now available in over 80 US rehabilitation centers (around 25% of specialized centers) representing solid market penetration for its first year. The company expects an acceleration of ARC-EX uptake in 2026 thanks to the home use label with particula...
ONWARD Medical Reports Full Year 2025 Financial and Operating Results, Highlighting Strong US Commercial Performance and Major Pipeline Milestones THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) EINDHOVEN, the Netherlands, March 31, 2026 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injuries (SCI) and other movement disabilities, today announces i...
ARGAN : Compte-rendu de l'Assemblée Générale Mixte du 26 mars 2026 Communiqué de presse – Neuilly-sur-Seine, vendredi 27 mars 2026 - 8h00 Assemblée Générale Mixte ARGAN du 26 mars 2026 Un plan de développement 2026 soutenu : 165 M€ d’investissements sécurisésHausse du Dividende de 5 % (à 3,45 € par action) sur la base d’une excellente performance en 2025 Approbation de toutes les résolutions soutenues par le Directoire et le Conseil de Surveillance L’assemblée générale mixte des actionnaires d’ARGAN s’est réunie le jeudi 26 mars 2026 dans les locaux du Hyatt Regency à Paris. ARGAN confi...
ARGAN: Summary of the 2026 Combined General Meeting of Shareholders Press release – Neuilly-sur-Seine, Friday, March 27, 2026 – 8.00 am ARGAN COMBINED GENERAL MEETING – MARCH 26, 2026 A sustained 2026 development plan: €165 million in secured investments 5% increase in the dividend (to €3.45 per share) based on excellent performance in 2025 Approval of all resolutions supported by the Executive Board and the Supervisory Board The Combined General Meeting of ARGAN’s shareholders was held on Thursday, March 26, 2026, at the Hyatt Regency in Paris. ARGAN confirmed a sustained development p...
Geopolitical risk has resurfaced, but the nearterm impact on European listed real estate remains contained. Rising energydriven inflation and rates are driving greater dispersion and sharpening the focus on balancesheet quality, while MIPIM 2026 highlighted a pragmatic investor approach. In this report, we adjust target prices and refresh our top picks, removing CTP and adding Irish Residential REIT. Geopolitics and energy: duration matters more than headlines
ONWARD Medical Schedules Webcast to Report Full-Year 2025 Financial Results and Provide Business Update EINDHOVEN, the Netherlands, March 23, 2026 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injury and other movement disabilities, today announces that it will report Full-Year 2025 Financial Results and host a webcast to provide a comprehensive business update on March 31, 2026. Presented by CEO Dave Marver, the webcast will be h...
ARGAN: 2025 UNIVERSAL REGISTRATION DOCUMENT MADE AVAILABLE IN ENGLISH Press release – Neuilly-sur-Seine, Friday, March 13, 2026 – 5.45pm 2025 Universal Registration Document made available in English ARGAN informs the public that the 2025 Universal Registration Document, previously filed in French on Monday, March 2, with the French financial markets authority (AMF) under number D.26-0059, is now available in its English translation. This English version of the Universal Registration Document is thus available on the company's website () under the heading of Investors & Shareholders / 2...
ARGAN : MISE À DISPOSITION DU DOCUMENT D’ENREGISTREMENT UNIVERSEL 2025 EN VERSION ANGLAISE Communiqué de presse – Neuilly-sur-Seine, vendredi 13 mars 2026 - 17h45 Mise à disposition du Document d’Enregistrement Universel 2025 en version anglaise ARGAN informe le public que le Document d’Enregistrement Universel 2025, précédemment déposé en français le lundi 2 mars auprès de l’Autorité des Marchés Financiers sous le numéro D.26-0059, est à présent disponible traduit en anglais. Le Document d’Enregistrement Universel en version anglaise peut être consulté sur le site internet de la société...
ARGAN leases 32,000 sq.m at its Coudray-Montceaux (91) site, bringing portfolio occupancy back to 100% Press release – Neuilly-sur-Seine, Tuesday, March 10, 2026 – 5.45 pm ARGAN leases 32,000 sq.m at its Coudray-Montceaux (91) site, bringing portfolio occupancy back to 100% Photo credits: ARGAN The Le Coudray-Montceaux site remained vacant for only a few months before JS LOGISTICS signed a lease for the 32,000 sq.m available within this two-building complex totaling 163,000 sq.m, located in the southern part of the Paris region. With direct access to the A6 motorway and located about ...
ARGAN loue 32 000 m² sur son site du Coudray-Montceaux (91) et ramène le taux d’occupation de son patrimoine à 100% Communiqué de presse – Neuilly-sur-Seine, mardi 10 mars 2026 – 17h45 ARGAN loue 32 000 m² sur son site du Coudray-Montceaux (91) et ramène le taux d’occupation de son patrimoine à 100% Crédit : ARGAN Le site du Coudray-Montceaux ne sera resté vacant que quelques mois avec la prise à bail par JS LOGISTICS des 32 000 m² disponibles sur cet ensemble de deux bâtiments représentant un total de 163 000 m² situé au sud de la région francilienne. En accès direct sur l’autoroute A6...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.